|
Volumn 50, Issue 57, 2014, Pages 7632-7635
|
A hyaluronic acid–methotrexate conjugate for targeted therapy of rheumatoid arthritis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYALURONIC ACID;
METHOTREXATE;
ANTIRHEUMATIC AGENT;
DRUG COMBINATION;
IMMUNOLOGICAL ADJUVANT;
ARTICLE;
ARTICULAR CARTILAGE;
BONE EROSION;
CONJUGATE;
INFLAMMATORY CELL;
MACROPHAGE;
NONHUMAN;
PANNUS;
PH;
RHEUMATOID ARTHRITIS;
SYNOVIAL FLUID;
SYNOVITIS;
SYNOVIUM;
THERAPY EFFECT;
TISSUE SPECIFICITY;
ANIMAL;
ARTHRITIS, RHEUMATOID;
CELL LINE;
DRUG COMBINATION;
DRUG DELIVERY SYSTEM;
METABOLISM;
MOUSE;
PATHOLOGY;
PROCEDURES;
ADJUVANTS, IMMUNOLOGIC;
ANIMALS;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
CELL LINE;
DRUG COMBINATIONS;
DRUG DELIVERY SYSTEMS;
HYALURONIC ACID;
METHOTREXATE;
MICE;
|
EID: 84903162955
PISSN: 13597345
EISSN: 1364548X
Source Type: Journal
DOI: 10.1039/c4cc02595d Document Type: Article |
Times cited : (119)
|
References (16)
|